147 related articles for article (PubMed ID: 25228393)
21. Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2,5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors.
Kim KJ; Choi MJ; Shin JS; Kim M; Choi HE; Kang SM; Jin JH; Lee KT; Lee JY
Bioorg Med Chem Lett; 2014 Apr; 24(8):1958-62. PubMed ID: 24656662
[TBL] [Abstract][Full Text] [Related]
22. Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages.
Chen CW; Lee ST; Wu WT; Fu WM; Ho FM; Lin WW
Br J Pharmacol; 2003 Nov; 140(6):1077-87. PubMed ID: 14530214
[TBL] [Abstract][Full Text] [Related]
23. [Network target: a starting point for traditional Chinese medicine network pharmacology].
Li S
Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(15):2017-20. PubMed ID: 22066431
[TBL] [Abstract][Full Text] [Related]
24. Synergistic Effect of Compounds from a Chinese Herb: Compatibility and Dose Optimization of Compounds from N-Butanol Extract of Ipomoea stolonifera.
Cai C; Chen Y; Zhong S; Zhang Y; Jiang J; Xu H; Shi G
Sci Rep; 2016 Jun; 6():27014. PubMed ID: 27255791
[TBL] [Abstract][Full Text] [Related]
25. A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components.
Wang CH; Zhong Y; Zhang Y; Liu JP; Wang YF; Jia WN; Wang GC; Li Z; Zhu Y; Gao XM
Mol Biosyst; 2016 Feb; 12(2):606-13. PubMed ID: 26687282
[TBL] [Abstract][Full Text] [Related]
26. Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure.
Chen L; Cao Y; Zhang H; Lv D; Zhao Y; Liu Y; Ye G; Chai Y
J Ethnopharmacol; 2018 Jun; 219():359-368. PubMed ID: 29366769
[TBL] [Abstract][Full Text] [Related]
27. [HTRF-based high-throughput PGE2 release prohibition model and application in discovering traditional Chinese medicine active ingredients].
Bai ZR; Fei HQ; Li N; Cao L; Zhang CF; Wang TJ; Ding G; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):509-513. PubMed ID: 28868872
[TBL] [Abstract][Full Text] [Related]
28. San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators.
Lo YC; Tsai PL; Huang YB; Shen KP; Tsai YH; Wu YC; Lai YH; Chen IJ
J Ethnopharmacol; 2005 Jan; 96(1-2):99-106. PubMed ID: 15588656
[TBL] [Abstract][Full Text] [Related]
29. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease.
Tao W; Xu X; Wang X; Li B; Wang Y; Li Y; Yang L
J Ethnopharmacol; 2013 Jan; 145(1):1-10. PubMed ID: 23142198
[TBL] [Abstract][Full Text] [Related]
30. COX-2 as possible target for the inhibition of PGE2 production by Rikko-san in activated macrophage.
Horie N; Hashimoto K; Kato T; Shimoyama T; Kaneko T; Kusama K; Sakagami H
In Vivo; 2008; 22(3):333-6. PubMed ID: 18610745
[TBL] [Abstract][Full Text] [Related]
31. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages.
Kim KW; Ha KT; Park CS; Jin UH; Chang HW; Lee IS; Kim CH
Vascul Pharmacol; 2007; 47(2-3):99-107. PubMed ID: 17553752
[TBL] [Abstract][Full Text] [Related]
32. Traditional Chinese medicine network pharmacology: theory, methodology and application.
Li S; Zhang B
Chin J Nat Med; 2013 Mar; 11(2):110-20. PubMed ID: 23787177
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
34. A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection.
Yang H; Zhang W; Huang C; Zhou W; Yao Y; Wang Z; Li Y; Xiao W; Wang Y
BMC Complement Altern Med; 2014 Nov; 14():430. PubMed ID: 25366653
[TBL] [Abstract][Full Text] [Related]
35. A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout.
Zhao F; Guochun L; Yang Y; Shi L; Xu L; Yin L
J Ethnopharmacol; 2015 Jun; 168():1-16. PubMed ID: 25824593
[TBL] [Abstract][Full Text] [Related]
36. [Study on action mechanism of Danhong injection based on computational system biology approach].
Lv YN; Wei XH; Xiao P
Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(3):538-42. PubMed ID: 26084184
[TBL] [Abstract][Full Text] [Related]
37. Herb-target interaction network analysis helps to disclose molecular mechanism of traditional Chinese medicine.
Liang H; Ruan H; Ouyang Q; Lai L
Sci Rep; 2016 Nov; 6():36767. PubMed ID: 27833111
[TBL] [Abstract][Full Text] [Related]
38. Quantitative modeling of dose-response and drug combination based on pathway network.
Gu J; Zhang X; Ma Y; Li N; Luo F; Cao L; Wang Z; Yuan G; Chen L; Xiao W; Xu X
J Cheminform; 2015; 7():19. PubMed ID: 26101547
[TBL] [Abstract][Full Text] [Related]
39. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study.
Pradhan D; Priyadarshini V; Munikumar M; Swargam S; Umamaheswari A; Bitla A
J Biomol Struct Dyn; 2014; 32(2):171-85. PubMed ID: 23383626
[TBL] [Abstract][Full Text] [Related]
40. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.
Chang SS; Huang HJ; Chen CY
Mol Biosyst; 2011 Dec; 7(12):3366-74. PubMed ID: 22012120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
